Clinical Research Directory
Browse clinical research sites, groups, and studies.
5-HTP and Creatine for Depression R33 Phase
Sponsor: University of Utah
Summary
This is a three-armed clinical trial examining the effect of 5-hydroxytryptophan and creatine monohydrate as augmenting agents for the treatment of depression. Subjects will be randomized between 5-HTP 100mg BID + creatine 5g daily, 5-HTP 200mg BID + creatine 10g daily, vs double placebo, for 8 weeks. The ability of the interventions to affect biomarkers associated with depression will be assessed using brain phosphorus magnetic resonance spectroscopy, functional connectivity imaging, and plasma serotonin levels.
Official title: 31P-MRS and Resting State Functional Connectivity Analysis of the Effects of 5-hydroxytryptophan and Creatine for Antidepressant Augmentation in Patients With SSRI/SNRI-resistant Major Depressive Disorder
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
106
Start Date
2023-09-28
Completion Date
2026-07-31
Last Updated
2025-08-08
Healthy Volunteers
No
Conditions
Interventions
Low Dose 5-hydroxytryptophan
5-hydroxytryptophan 100mg PO BID
High Dose 5-hydroxytryptophan
5-hydroxytryptophan 200mg PO BID
Low Dose Creatine Monohydrate
Creatine monohydrate 5g PO qday
High Dose Creatine Monohydrate
Creatine monohydrate 10g PO qday
Placebo
Creatine-matched placebo and 5-HTP-matched placebo; Placebo will be dextrose either encapsulated (5-HTP matched) or as loose powder (creatine matched)
Locations (1)
University of Utah Department of Psychiatry
Salt Lake City, Utah, United States